Introduction to MedComm

MedComm is a full English biomedical journal published by Wiley, the largest publishing group in the United States (https://onlinelibrary.wiley.com/journal/26882663). The editor-in-chiefs are Professor James Henderson Naismith (Academician of the Royal Society and Academician of the Royal Society of Edinburgh) and Professor Wei Yuquan (Academician of the Chinese Academy of Sciences) from West China Hospital, Sichuan University. The associate editors and editors are famous scientists from over 10 countries in the world. MedComm is a peer-reviewed online open access (OA) journal that timely publishes basic research and clinical research in biomedicine, and strives to become a high-quality academic journal in biomedicine with international influence. The types of papers published in this journal include Review, Perspective, Research Article, Letter, Research Highlight, etc. A "quick passage" model is adopted for original achievements to help authors get their papers published in the shortest time, with reception procedure completed in one week at the quickest. The publication cost is waived from 2020 to 2022. With all sincerity, MedComm prepares itself for active submissions from researchers, doctors, and graduate students in biomedicine.